PellePharm's Topical Patidegib Nears Phase III For Gorlin Syndrome

Gel formulations of the hedgehog signalling inhibitor patidegib may be the long sought well-tolerated and effective therapy for basal cell carcinoma and the rare disease, Gorlin syndrome.